Ahmed M. Altibi, MD, MPH
Clinical FellowAbout
Research
Publications
2024
Factors associated with non-publication of clinical trials in cardiovascular medicine: a cross-sectional analysis
Alawajneh M, Aljabai A, Theeb L, Badwan Z, Alnabi A, Theeb H, Altibi A. Factors associated with non-publication of clinical trials in cardiovascular medicine: a cross-sectional analysis. European Heart Journal 2024, 45: ehae666.3639. DOI: 10.1093/eurheartj/ehae666.3639.Peer-Reviewed Original ResearchCross-sectional analysisClinical trialsIntervention typeLogistic regressionCardiovascular medicineNon-randomised trialsOpen-label trialPublication statusMultivariate logistic regressionArea of clinical researchEnrollment sizeNon-publicationCardiovascular clinical trialsCardiovascular-relatedParticipant ageTriple-blindTrial completionDecreased likelihoodRandomised trialsTrial publicationsPredictor factorsFunding sourcesResearch fundingClinical researchEnrollmentOutcomes of Adult Patients With COVID-19 Transitioning From Venovenous to Venoarterial or Hybrid Extracorporeal Membrane Oxygenation in the Extracorporeal Life Support Organization Registry.
Nguyen K, Altibi A, Prasad P, Mukundan S, Shekar K, Ramanathan K, Zakhary B. Outcomes of Adult Patients With COVID-19 Transitioning From Venovenous to Venoarterial or Hybrid Extracorporeal Membrane Oxygenation in the Extracorporeal Life Support Organization Registry. ASAIO Journal 2024 PMID: 38810234, DOI: 10.1097/mat.0000000000002243.Peer-Reviewed Original ResearchExtracorporeal membrane oxygenationVv-extracorporeal membrane oxygenationVenovenous extracorporeal membrane oxygenationExtracorporeal Life Support OrganizationMembrane oxygenationAdult patientsTreated with VV ECMOExtracorporeal Life Support Organization registryOutcomes of adult patientsFactors associated with conversionRisk factors associated with conversionIn-hospital mortality rateExtracorporeal membrane oxygenation configurationRenal replacement therapyLife Support OrganizationIn-hospital mortalityPrimary outcome measureRisk of mortalityRisk of conversionCOVID-19 patientsInotrope requirementPre-ECMOPropensity score matchingVA-ECMOInotropic agentsPO-06-028 SHORT-TERM OUTCOMES OF LEADLESS PACEMAKER IMPLANTATION IN THE UNITED STATES – INSIGHT FROM NATIONAL READMISSION DATABASE 2016-2020
Altibi A, Alhunaifat L, Ghanem F, Vashistha K, Stecker E, Sanghai S, Henrikson C. PO-06-028 SHORT-TERM OUTCOMES OF LEADLESS PACEMAKER IMPLANTATION IN THE UNITED STATES – INSIGHT FROM NATIONAL READMISSION DATABASE 2016-2020. Heart Rhythm 2024, 21: s672-s673. DOI: 10.1016/j.hrthm.2024.03.1653.Peer-Reviewed Original ResearchPO-06-086 STELLATE GANGLION BLOCKAGE FOR TREATMENT OF VENTRICULAR ARRHYTHMIA STORM: CHARACTERISTICS AND OUTCOMES FROM SINGLE-CENTER EXPERIENCE
Altibi A, Prasad M, Rhodes G, Stecker E, Henrikson C, Sanghai S. PO-06-086 STELLATE GANGLION BLOCKAGE FOR TREATMENT OF VENTRICULAR ARRHYTHMIA STORM: CHARACTERISTICS AND OUTCOMES FROM SINGLE-CENTER EXPERIENCE. Heart Rhythm 2024, 21: s702. DOI: 10.1016/j.hrthm.2024.03.1712.Peer-Reviewed Original ResearchPO-03-166 CHARACTERISTICS AND 5-YEAR TREND IN LEADLESS PACEMAKER IMPLANTATION IN THE UNITED STATES – INSIGHT FROM NATIONAL READMISSION DATABASE (2016-2020)
Altibi A, Alhunaifat L, Ghanem F, Vashistha K, Stecker E, Sanghai S, Henrikson C. PO-03-166 CHARACTERISTICS AND 5-YEAR TREND IN LEADLESS PACEMAKER IMPLANTATION IN THE UNITED STATES – INSIGHT FROM NATIONAL READMISSION DATABASE (2016-2020). Heart Rhythm 2024, 21: s363. DOI: 10.1016/j.hrthm.2024.03.1006.Peer-Reviewed Original ResearchNormal-Flow Low-Gradient Aortic Stenosis Comparing the U.S. and European Guidelines
Elkaryoni A, Huded C, Saad M, Altibi A, Chhatriwalla A, Abbott J, Arnold S. Normal-Flow Low-Gradient Aortic Stenosis Comparing the U.S. and European Guidelines. JACC Cardiovascular Imaging 2024, 17: 926-936. PMID: 38703172, DOI: 10.1016/j.jcmg.2024.03.005.Peer-Reviewed Original ResearchNormal-flow low-gradientSevere aortic stenosisModerate aortic stenosisAortic stenosisValve replacementEuropean Society of Cardiology/European Association for Cardio-Thoracic Surgery guidelinesAmerican Heart Association/American College of Cardiology guidelinesLow-gradient aortic stenosisLow-gradient severe aortic stenosisAmerican Heart Association/American CollegeAortic valve replacementOutcomes of patientsSurgery guidelinesSurvival benefitCardiology guidelinesClinical entityStenosisDiagnostic algorithmEuropean guidelinesNatural historyPatientsEuropean AssociationPotential diagnostic algorithmsEuropean SocietyOutcomesCerebral embolic protection device utilization and outcomes in transcatheter aortic valve replacement: A nationally representative propensity matched analysis
Altibi A, Alhuneafat L, Jabri A, Al-Abdouh A, Ghanem F. Cerebral embolic protection device utilization and outcomes in transcatheter aortic valve replacement: A nationally representative propensity matched analysis. Cardiovascular Revascularization Medicine 2024, 67: 112-114. PMID: 38653674, DOI: 10.1016/j.carrev.2024.04.003.Peer-Reviewed Original ResearchTranscatheter aortic valve replacementCerebral embolic protection devicesAortic valve replacementPropensity score matchingNational Readmission DatabaseIn-hospital strokeValve replacementIn-hospitalPeriprocedural strokeOdds ratioTranscatheter aortic valve replacement patientsTransfemoral transcatheter aortic valve replacementPropensity score matched cohortAssociated with decreased riskScore matchingPropensity matched analysisRisk of periprocedural strokeRisk of in-hospital strokeAcute kidney injuryTAVR admissionsIn-hospital mortalityConfidence intervalsOutcomes post-TAVRAssociated with reduced oddsEmbolic protection devicesDEATH TRENDS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY IN EMERGENCY DEPARTMENTS IN THE UNITED STATES
Sapru A, Altibi A, Elman M, Masri A. DEATH TRENDS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY IN EMERGENCY DEPARTMENTS IN THE UNITED STATES. Journal Of The American College Of Cardiology 2024, 83: 538. DOI: 10.1016/s0735-1097(24)02528-2.Peer-Reviewed Original ResearchFACTORS ASSOCIATED WITH NON-PUBLICATION OF CLINICAL TRIALS IN HEART FAILURE; A CROSS-SECTIONAL ANALYSIS
Aljabali A, AlAwajneh M, Theeb L, Tashtoush S, Alshwayyat S, Altibi A. FACTORS ASSOCIATED WITH NON-PUBLICATION OF CLINICAL TRIALS IN HEART FAILURE; A CROSS-SECTIONAL ANALYSIS. Journal Of The American College Of Cardiology 2024, 83: 799. DOI: 10.1016/s0735-1097(24)02789-x.Peer-Reviewed Original ResearchIMPACT OF COVID-19 PANDEMIC ON THE PROCEDURAL VOLUMES AND OUTCOMES OF CARDIAC ELECTROPHYSIOLOGY PROCEDURES IN THE UNITED STATES
Altibi A, Hashem A, Ghanem F, Sanghai S, Nazer B, Stecker E, Henrikson C. IMPACT OF COVID-19 PANDEMIC ON THE PROCEDURAL VOLUMES AND OUTCOMES OF CARDIAC ELECTROPHYSIOLOGY PROCEDURES IN THE UNITED STATES. Journal Of The American College Of Cardiology 2024, 83: 169. DOI: 10.1016/s0735-1097(24)02159-4.Peer-Reviewed Original Research